The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Correlation of ABI1 and PTEN expression during prostate tumor progression.
 
Leszek Kotula
No Relationships to Disclose
 
Anita Hryniewicz-Jankowska
No Relationships to Disclose
 
Xiang Li
No Relationships to Disclose
 
Katarzyna Augoff
No Relationships to Disclose
 
Csaba Papp
No Relationships to Disclose
 
Disharee Das
No Relationships to Disclose
 
Sonia H.Y. Kung
No Relationships to Disclose
 
Ladan Fazli
No Relationships to Disclose
 
Tamara Jasmaspishvili
No Relationships to Disclose
 
David Monty Berman
No Relationships to Disclose
 
Fan Zhang
No Relationships to Disclose
 
Baylee Porter
No Relationships to Disclose
 
Aleksander Sikorski
No Relationships to Disclose
 
Martin Gleave
Stock and Other Ownership Interests - Sitka; Sustained Therapeutics
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Genova Diagnostics; Janssen; Pfizer; Roche; Sanofi; Tersera
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Genova Diagnostics; Janssen; Pfizer; Roche; Sanofi; Tersera
Research Funding - Astellas Pharma; Bayer; Janssen
Patents, Royalties, Other Intellectual Property - OncoGenex - OGX-011, OGX-427; Sitka - preclinical company focused on novel formulations of taxanes as intravesical agents for superficial bladder cancer; ST-CP; ST-POP
 
Vladimir Kuznetsov
No Relationships to Disclose
 
Gennady Bratslavsky
Employment - AptaMatrix
Leadership - Taurus Diagnostics
Stock and Other Ownership Interests - Ilgen; Respiquest
Consulting or Advisory Role - Johnson & Johnson/Janssen; Novartis